市場調查報告書
商品編碼
1273564
止血閥市場預測到 2028 年-按類型(單手止血閥、雙 Y 連接器止血閥、止血閥 Y 連接器、其他類型)、按應用、按最終用戶、按地區分類的全球分析Hemostasis Valve Market Forecasts to 2028 - Global Analysis By Type (One-handed Hemostasis Valves, Double Y-connector Hemostasis Valves, Hemostasis Valve Y-connectors and Other Types), Application, End User and By Geography |
根據 Stratistics MRC 的數據,2022 年全球止血閥市場規模將達到 1722 億美元,預計到 2028 年將達到 2556 億美元,預測期內復合年增長率為 6.8%。成長。
止血閥組用於在手術過程中連接或引入導管和導絲。 當介入裝置被放置在人體循環系統中時,止血閥旨在用作導管。 止血閥常用於神經血管內手術,以降低血栓形成的風險。 新的止血閥也正在開發中,旨在最大限度地減少出血。
根據世界衛生組織 (WHO) 的數據,心血管疾病每年導致約 1790 萬人死亡,成為全球第一大死因。
止血閥常用於心血管手術,以阻止失血並減少潛在問題。 被稱為心血管疾病的疾病是那些損害心臟和血液動脈的疾病。 通過幫助外科醫生控制出血和減少並發症,止血閥在這些手術中是必不可少的。 心血管疾病患病率的增加是市場的主要驅動力之一。
普通大眾對止血閥的了解非常少。 缺乏關於這些小工具的知識。 止血閥的可用性是有限的。 止血閥安裝在體內以控制出血。 瓣膜內血凝塊的發展是一種被稱為瓣膜病的可能性。 此外,技術問題和止血閥導致空氣栓塞的可能性預計將抑制市場擴張。
在手術過程中減少切口稱為微創手術。 由於其優於傳統程序,這些程序正變得越來越流行。 該瓣膜對於手術至關重要,因為它在微創手術中起到控制出血的作用。 因此,越來越多地使用微創手術是市場擴張的推動力。
金屬、聚合物和陶瓷只是用於製造止血閥的部分材料。 製造過程複雜且這些材料昂貴。 因此,止血閥價格昂貴。 市場上的一大問題是止血閥的價格。 然而,止血閥的高價格和合格醫師的短缺限制了市場的擴張。
隨著越來越多的人感染 COVID-19,可用的控制設備激增。 儘管設備種類繁多,但霧化器、氧氣發生器、生命支持設備和監護儀等呼吸支持設備是重症臨床護理中最常用的醫療設備。 手套、口罩和護目鏡只是可能因大流行而被用作個人防護設備的醫療產品的幾個例子。 醫療專業人員和公眾都注意到用於預防的此類設備和個人防護設備的增加。
隨著止血閥 Y 型連接器在各種醫療程序中的應用越來越多,預計該領域將實現有利可圖的增長。 Y 型連接器在導管插入過程中提供可靠的密封。 它也非常易於使用,幾乎不需要對醫務人員進行培訓。 此外,止血閥的創新使更好的設計成為可能,從而提供更高的療效和更低的感染風險。
由於心血管疾病患病率的增加,預計在預測期內,醫院部門將以最快的複合年增長率增長。 這部分是因為隨著發展中國家基礎設施建設的進步,希望在醫院接受手術的患者數量增加,導致醫院數量增加。 包括健康飲食、支持服務、良好環境和患者安全在內的基礎設施將在增加對醫院的需求方面發揮關鍵作用。
由於心血管疾病患病率上升,亞太地區預計在預測期內將佔據最大的市場份額。 不斷上升的醫療保健成本和對微創手術的需求增加也在增加市場價值。 區域投資也是由於該領域領導者的興趣和支出增加,以及正在進行的合作項目。 此外,醫院數量的擴大和醫療旅遊也是影響該地區發展的因素。
預計歐洲在預測期內的複合年增長率最高。 這是由於癌症患病率上升以及醫療保健部門的戰略政策和投資所致。 在此背景下,心血管疾病的發病率不斷上升,而患者偏愛微創手術。 該地區的增長是由老年人口增加、介入手術需求和健康意識等原因推動的。
2020 年 12 月,全球領先的醫療保健產品和服務提供商 Teleflex, Inc. 宣布完成其宣布的對該行業止血產品製造商 Z-Medica, LLC 的收購。做到了。
2020 年 11 月,Freudenberg Medical 最近在馬薩諸塞州建立了全球總部,並在馬薩諸塞州貝弗利建立了一個新的醫療生產設施。
訂閱此報告的客戶將獲得以下免費定制選項之一。
According to Stratistics MRC, the Global Hemostasis Valve Market is accounted for $172.2 billion in 2022 and is expected to reach $255.6 billion by 2028 growing at a CAGR of 6.8% during the forecast period. Hemostasis valve sets are used to connect or introduce catheters and guide wires during surgery. When interventional devices are placed into the human circulatory system, hemostasis valve is intended to be employed as a conduit. In neuroendovascular surgeries, a hemostasis valve is typically employed to lower the risk of thrombosis. A new hemostasis valve that is intended to minimise blood loss has also been developed.
According to the World Health Organization (WHO), CVDs are responsible for approximately 17.9 million deaths each year, making them the leading cause of death globally.
Hemostasis valves are frequently employed during cardiovascular procedures to stop blood loss and lessen the possibility of problems. A category of conditions known as cardiovascular illnesses damage the heart and blood arteries. By assisting surgeons in controlling bleeding and reducing complications, hemostasis valves are essential in these operations. Increase in prevalence of cardiovascular diseases is one of the key drivers of the market.
The general population has little knowledge of hemostasis valves. There is a shortage of knowledge on these gadgets. The availability of hemostasis valves is limited. The body is fitted with hemostasis valves to regulate bleeding. A blood clot developing in the valve is a possibility known as valve thrombosis. Additionally, it is anticipated that technical issues and the potential for air embolism caused by the hemostasis valve may restrain market expansion.
Smaller incisions during surgery are referred to as minimally invasive techniques. Due to the advantages these procedures provide over more conventional procedures, they are becoming more and more popular. Due to its role in regulating bleeding during minimally invasive surgeries, this valve is a crucial part of those operations. Therefore, a rise in the use of less invasive procedures is driving market expansion.
Metals, polymers, and ceramics are just a few of the materials used to make hemostasis valves. The production process is intricate, and these materials are pricey. Hemostasis valves are hence costly. One of the biggest issues facing the market is the price of hemostasis valves. The expensive price of hemostasis valves and the scarcity of qualified doctors, however, are limiting market expansion.
Numerous people are becoming infected with COVID-19, which has led to a sharp increase in the amount of available management equipment. There are many different equipment, but respiratory support devices such atomizers, oxygen generators, life support machines, and monitors are among the most commonly utilised medical devices in critical clinical treatment. Gloves, masks, and protective eyewear are just a few of the medical products that might be employed as personal protection equipment as a result of the pandemic. Both medical experts and the general public have noticed an increase in such devices and personal protection equipment as preventative measures.
The hemostasis valve y-connectors segment is estimated to have a lucrative growth, due to they are increasingly used in various medical procedures. Y-connectors give catheterization procedures a reliable seal. They are very simple to use and require little training for medical personnel. Furthermore, superior designs that offer greater efficacy and a lower risk of infection have been made possible by technological breakthroughs in hemostasis valves.
The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increase in prevalence of cardiovascular diseases. This is partly because there are more hospitals in developing nations as a result of initiatives for infrastructure construction and a rise in the number of patients who want to have surgery in a hospital. Infrastructures including wholesome food, support services, a positive environment, and patient safety will play a significant role in raising demand for hospitals.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the rise in prevalence of cardiovascular diseases. The market value is also being boosted by rising healthcare costs and an increase in demand for minimally invasive surgeries. Regional investment is also due to growing sector leaders' interest and spending as well as continuous collaborative projects. Additionally, expanding hospital numbers and medical tourism are some of the elements influencing the development of the regional sector.
Europe is projected to have the highest CAGR over the forecast period, owing to the elevated prevalence of cancer coupled with strategic policies and investment in the healthcare sector. This is brought on by the rising incidence of cardiovascular disorders and patients' choice for minimally invasive procedures. The region's growth is being fueled by reasons such as an increase in senior population, interventional surgery demand, and health awareness.
Some of the key players profiled in the Hemostasis Valve Market include: Terumo Corporation, Freudenberg Medical, Boston Scientific Corporation, Merit Medical Systems, Teleflex Incorporated, B. Braun Melsungen, Argon Medical, DeRoyal Industries, Abbott Laboratories , Argon Medical Devices, Excel Medical Products, Qosina Corporation and Scitech.
In December 2020, Teleflex Incorporated, a leading global provider of health - care items and services, announced that it has completed the announced acquisition of Z-Medica, LLC, a sector manufacturing company of hemostatic products.
In November 2020, Freudenberg Medical recently built its worldwide headquarters in Massachusetts and its new medical production facility in Beverly, Massachusetts.
All the customers of this report will be entitled to receive one of the following free customization options: